RLMD vs UPST · $692.3M cap vs P/E 74, rev $672.9M
Relmada Therapeutics Inc (RLMD) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
RLMD does not have a complete income-statement cache yet.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
RLMD currently screens at market cap $692.3M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the RLMD and UPST stock pages for the full models.
Not investment advice.